Glasgow Caledonian University   Report issue

Academic/Hospital Phase 4
Founded: Glasgow United Kingdom (1993)

Organization Overview

First Clinical Trial
2010
NCT02478372
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Glasgow Caledonian University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 7